740 related articles for article (PubMed ID: 10084743)
21. Propagation and characterization of lymphocytes from rejecting human cardiac allografts.
Carlquist JF; Hammond EH; Anderson JL
J Heart Transplant; 1988; 7(6):397-406. PubMed ID: 3062146
[TBL] [Abstract][Full Text] [Related]
22. Heat shock protein-induced T-lymphocyte propagation from endomyocardial biopsies in heart transplantation.
Moliterno R; Woan M; Bentlejewski C; Qian J; Zeevi A; Pham S; Griffith BP; Duquesnoy RJ
J Heart Lung Transplant; 1995; 14(2):329-37. PubMed ID: 7779853
[TBL] [Abstract][Full Text] [Related]
23. Poor diagnostic value of in situ hybridization and immunohistochemistry in endomyocardial biopsies to detect cytomegalovirus after heart transplantation.
Bruneval P; Amrein C; Guillemain R; Belair MF; Bariety J
J Heart Lung Transplant; 1992; 11(4 Pt 1):773-7. PubMed ID: 1323328
[TBL] [Abstract][Full Text] [Related]
24. A comparison of the cytology of endomyocardial biopsy washings from heart transplants with biopsy histologic study and peripheral blood lymphocyte counts.
Clelland C; Fielding S; Storie I; Kennedy A; Smith G; Locke T
J Heart Lung Transplant; 1997 May; 16(5):477-83. PubMed ID: 9171264
[TBL] [Abstract][Full Text] [Related]
25. Endothelin plasma levels in acute graft rejection after heart transplantation.
Dengler TJ; Zimmermann R; Tiefenbacher CP; Braun K; Sack FU; Kübler W
J Heart Lung Transplant; 1995; 14(6 Pt 1):1057-64. PubMed ID: 8719451
[TBL] [Abstract][Full Text] [Related]
26. Heart allograft rejection under varying immunosuppressive protocols as evaluated by endomyocardial biopsy.
Imakita M; Tazelaar HD; Billingham ME
J Heart Transplant; 1986; 5(4):279-85. PubMed ID: 3305819
[TBL] [Abstract][Full Text] [Related]
27. Clinical heart transplantation without routine endomyocardial biopsy.
Warnecke H; Müller J; Cohnert T; Hummel M; Spiegelsberger S; Siniawski HK; Lieback E; Hetzer R
J Heart Lung Transplant; 1992; 11(6):1093-102. PubMed ID: 1457433
[TBL] [Abstract][Full Text] [Related]
28. The nature of acute rejection is associated with development of graft vascular disease after clinical heart transplantation.
Baan CC; Holweg CT; Niesters HG; van Gelder T; Mol WM; Zondervan PE; Mochtar B; Balk AH; Weimar W
J Heart Lung Transplant; 1998 Apr; 17(4):363-73. PubMed ID: 9588581
[TBL] [Abstract][Full Text] [Related]
29. The yield of surveillance endomyocardial biopsies as a screen for cellular rejection in pediatric heart transplant patients.
Levi DS; DeConde AS; Fishbein MC; Burch C; Alejos JC; Wetzel GT
Pediatr Transplant; 2004 Feb; 8(1):22-8. PubMed ID: 15009837
[TBL] [Abstract][Full Text] [Related]
30. Lymphocyte status in endomyocardial biopsies and blood after heart transplantation.
Schuurman HJ; Gmelig Meyling FH; Wijngaard PL; Van der Meulen A; Slootweg PJ; Jambroes G
J Pathol; 1989 Nov; 159(3):197-203. PubMed ID: 2574232
[TBL] [Abstract][Full Text] [Related]
31. A semiquantitative approach to the evaluation of acute cardiac allograft rejection at endomyocardial biopsy.
Frigerio M; Bonacina E; Gronda E; Andreuzzi B; Anjos MC; De Vita C; Mangiavacchi M; Masciocco G; Oliva F; Pellegrini A
J Heart Lung Transplant; 1997 Nov; 16(11):1087-98. PubMed ID: 9402507
[TBL] [Abstract][Full Text] [Related]
32. Identifying cardiac transplant rejection in children: diagnostic utility of echocardiography, right heart catheterization and endomyocardial biopsy data.
Rosenthal DN; Chin C; Nishimura K; Perry SB; Robbins RC; Reitz B; Bernstein D; Feinstein JA
J Heart Lung Transplant; 2004 Mar; 23(3):323-9. PubMed ID: 15019642
[TBL] [Abstract][Full Text] [Related]
33. Advantages of C2 monitoring to avoid acute rejection in pediatric heart transplant recipients.
Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Hübler M; Abd El Rahman MY; Miera O; Ewert P; Weng Y; Wei H; Krüdewagen B; Hetzer R; Berger F
J Heart Lung Transplant; 2006 Jun; 25(6):619-25. PubMed ID: 16730566
[TBL] [Abstract][Full Text] [Related]
34. "Quilty effect" in heart transplantation: is it related to acute rejection?
Pardo-Mindán FJ; Lozano MD
J Heart Lung Transplant; 1991; 10(6):937-41. PubMed ID: 1756159
[TBL] [Abstract][Full Text] [Related]
35. Persistence of interstitial inflammation after episodes of cardiac rejection associated with systemic infection.
Durham JR; Nakhleh RE; Levine A; Levine TB
J Heart Lung Transplant; 1995; 14(4):774-80. PubMed ID: 7578188
[TBL] [Abstract][Full Text] [Related]
36. In vitro studies of endomyocardial biopsies from heart transplant recipients on RATG and OKT3 immunoprophylaxis protocols.
Kaufman C; Zeevi A; Zerbe T; Kormos R; Griffith B; Hardesty R; Duquesnoy RJ
Transplantation; 1989 Oct; 48(4):621-5. PubMed ID: 2799915
[TBL] [Abstract][Full Text] [Related]
37. [The clinicopathological endomyocardial biopsy analysis in cardiac transplant recipients due to end-stage heart failure].
Li L; Zhao H; Wang HY; Lü FY; Liu L; Wang QZ; Si WX
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):819-21. PubMed ID: 17217692
[TBL] [Abstract][Full Text] [Related]
38. Association of viral genome with graft loss in children after cardiac transplantation.
Shirali GS; Ni J; Chinnock RE; Johnston JK; Rosenthal GL; Bowles NE; Towbin JA
N Engl J Med; 2001 May; 344(20):1498-503. PubMed ID: 11357152
[TBL] [Abstract][Full Text] [Related]
39. Cytoimmunologic monitoring and heart transplantation.
Hanson CA; Bolling SF; Stoolman LM; Schlegelmilch JA; Abrams GD; Miska PT; Deeb GM
J Heart Transplant; 1988; 7(6):424-9. PubMed ID: 3062148
[TBL] [Abstract][Full Text] [Related]
40. Intragraft monitoring of rejection after prophylactic treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in heart transplant recipients.
van Gelder T; Mulder AH; Balk AH; Mochtar B; Hesse CJ; Baan CC; Vaessen LM; Weimar W
J Heart Lung Transplant; 1995; 14(2):346-50. PubMed ID: 7779855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
